TP53 and Li-Fraumeni syndrome: Although p53 is widely mutated in human cancers and individuals with Li-Fraumeni syndrome have an elevated risk of breast cancer, this population comprises a small percentage of those with breast cancer, stressing the importance for cooperating genes in the initiation and/or progression of disease [11].